May 6
|
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
|
May 1
|
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
|
May 1
|
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
|
Apr 30
|
Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
|
Apr 26
|
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
|
Apr 23
|
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
|
Apr 1
|
Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 28
|
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
|
Mar 19
|
Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
Mar 14
|
Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
|
Mar 11
|
Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
|
Mar 11
|
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
|
Feb 15
|
BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
|
Feb 14
|
Has Apellis Pharmaceuticals (APLS) Outpaced Other Medical Stocks This Year?
|
Feb 13
|
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
|
Jan 12
|
Apellis (APLS): Strong Industry, Solid Earnings Estimate Revisions
|
Jan 9
|
Apellis (APLS) Up on Strong Q4 Preliminary Syfovre U.S. Revenues
|
Jan 9
|
Apellis Pharmaceuticals, Inc. (APLS) Soars 14.7%: Is Further Upside Left in the Stock?
|
Jan 2
|
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|